US EditionAdherence Patterns of Oral vs Injectable GLP-1 Receptor Agonists: A National Real-World Analysis of Commercial Claims Data, 2010–2021
Summary by researchsquare.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Adherence Patterns of Oral vs Injectable GLP-1 Receptor Agonists: A National Real-World Analysis of Commercial Claims Data, 2010–2021
Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly important in managing type 2 diabetes and obesity, but their effectiveness is limited by adherence challenges. While once-weekly injectable formulations may improve adherence compared to daily op...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
